Medpace Holdings, Inc. MEDP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.35% | 24.67% | 24.19% | 19.97% | 13.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.35% | 24.67% | 24.19% | 19.97% | 13.88% |
| Cost of Revenue | 9.80% | 9.48% | 9.32% | 7.34% | 5.69% |
| Gross Profit | 24.97% | 31.65% | 31.16% | 26.01% | 17.88% |
| SG&A Expenses | -2.71% | -5.12% | -3.31% | 9.64% | 11.74% |
| Depreciation & Amortization | -4.11% | -4.05% | -3.73% | -3.85% | -0.76% |
| Other Operating Expenses | 34.85% | 47.29% | 45.45% | 34.62% | 16.73% |
| Total Operating Expenses | 20.52% | 25.34% | 24.41% | 20.04% | 11.39% |
| Operating Income | 19.74% | 22.18% | 23.36% | 19.71% | 24.03% |
| Income Before Tax | 20.71% | 20.91% | 18.80% | 13.96% | 20.03% |
| Income Tax Expenses | 26.33% | 39.39% | 71.60% | 27.56% | 28.83% |
| Earnings from Continuing Operations | 19.59% | 17.50% | 10.57% | 11.56% | 18.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.59% | 17.50% | 10.57% | 11.56% | 18.42% |
| EBIT | 19.74% | 22.18% | 23.36% | 19.71% | 24.03% |
| EBITDA | 18.47% | 20.68% | 21.73% | 18.26% | 22.40% |
| EPS Basic | 25.27% | 25.90% | 20.21% | 19.85% | 23.90% |
| Normalized Basic EPS | 25.99% | 29.26% | 29.20% | 22.70% | 26.04% |
| EPS Diluted | 26.08% | 26.76% | 21.37% | 21.05% | 25.23% |
| Normalized Diluted EPS | 26.88% | 30.17% | 30.44% | 23.96% | 27.36% |
| Average Basic Shares Outstanding | -4.42% | -6.56% | -8.02% | -6.79% | -4.47% |
| Average Diluted Shares Outstanding | -5.10% | -7.24% | -8.93% | -7.75% | -5.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |